Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | SELE | P16581 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.48 |
| ▸ | STAT3 | P40763 | 4/20 | 0.46 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | TYR | P14679 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4265622 | 1.00 | AMY1A (0.55) | AMY1AL3MBTL1MEN1KMT2AMAPT | |
| SCHEMBL17072443 | 1.00 | AMY1A (0.55) | AMY1AL3MBTL1MEN1KMT2AMAPT | |
| SCHEMBL6914548 | 1.00 | AMY1A (0.55) | AMY1AL3MBTL1MEN1KMT2AMAPT | |
| SCHEMBL1096608 | 1.00 | AMY1A (0.55) | AMY1AL3MBTL1MEN1KMT2AMAPT | |
| SCHEMBL7545171 | 1.00 | AMY1A (0.55) | AMY1AL3MBTL1MEN1KMT2AMAPT | |
| SCHEMBL301721 | 1.00 | AMY1A (0.55) | AMY1AL3MBTL1MEN1KMT2AMAPT | |
| SCHEMBL10620884 | 1.00 | AMY1A (0.55) | AMY1AL3MBTL1MEN1KMT2AMAPT | |
| SCHEMBL17072438 | 1.00 | AMY1A (0.55) | AMY1AL3MBTL1MEN1KMT2AMAPT | |
| SCHEMBL9939094 | 1.00 | AMY1A (0.55) | AMY1AL3MBTL1MEN1KMT2AMAPT | |
| SCHEMBL29572443 | 1.00 | AMY1A (0.55) | AMY1AL3MBTL1MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5993889-A | A D-GLUCOSYL-TRANSFERRED SACCHARIDE, SAID COMPOSITION ALSO CONTAINING PORTIONS OF BETA-D-GLUCOSE-1-PHOSPORHIC ACID ITS SALT OR A MIXTURE THEREOF, AND ANOTHER SACCHARIDE | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 1999-11-30 | — | — | US | claimed |
| US-20120258043-A1 | Linkable Lewis X Analogs | BRACCO SUISSE S.A. (CH) | 2012-10-11 | — | — | US | disclosed |
| US-20110229409-A1 | LINKABLE LEWIS X ANALOGS | BRACCO INTERNATIONAL B.V. (NL) | 2011-09-22 | — | — | US | disclosed |
| US-20080300220-A1 | Linkable Lewis X Analogs | BRACCO INTERNATIONAL B.V. (NL) | 2008-12-04 | — | — | US | disclosed |
| US-7422733-B2 | Linkable sialyl Lewis X analogs | BRACCO INTERNATIONAL B.V. (NL) | 2008-09-09 | — | — | US | disclosed |
| EP-0841397-B1 | Trehalose phosphorylase, its preparation and uses | HAYASHIBARA BIOCHEM LAB (JP) | 2006-01-18 | — | — | EP | disclosed |
| US-20040097403-A1 | Linkable sialyl lewis x analogs | BRACCO SUISSE SA (CH) | 2004-05-20 | — | — | US | disclosed |
| EP-1337539-A2 | LINKABLE SIALYL LEWIS X ANALOGS | BRACCO INTERNATIONAL B.V. (NL) | 2003-08-27 | — | — | EP | disclosed |
| WO-2002062810-A2 | LINKABLE SIALYL LEWIS X ANALOGS | BRACCO INTERNATIONAL B.V. (NL) | 2002-08-15 | — | — | WO | disclosed |
| US-5993889-A | A D-GLUCOSYL-TRANSFERRED SACCHARIDE, SAID COMPOSITION ALSO CONTAINING PORTIONS OF BETA-D-GLUCOSE-1-PHOSPORHIC ACID ITS SALT OR A MIXTURE THEREOF, AND ANOTHER SACCHARIDE | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 1999-11-30 | — | — | US | disclosed |
| US-5910436-A | CULTURE PRODUCT | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 1999-06-08 | — | — | US | disclosed |
| US-5876975-A | CONTACTING TREHALOSE PHOSPHORYLASE OBTAINED FROM THERMOANAEROBIUM GENUS WITH BETA-D-GLUCOSE-1-PHOSPHORIC ACID AND ANOTHER SACCHARIDE TO PRODUCE D-GLUCOSYL-TRANSFERRED SACCHARIDE | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 1999-03-02 | — | — | US | disclosed |
| US-5843748-A | Trehalose phosphorylase its preparation and uses | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 1998-12-01 | — | — | US | disclosed |
| WO-1998030572-A1 | PROCESSES FOR THE PREPARATION OF αGal(1→4)βGal(1→4)Glc-OR | SYNSORB BIOTECH, INC. (CA) | 1998-07-16 | — | — | WO | disclosed |
| EP-0841397-A2 | Trehalose phosphorylase, its preparation and uses | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 1998-05-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080300220-A1 | Linkable Lewis X Analogs | SSB, SELPLG, SELL | AMY1A 3697/4885L3MBTL1 555/4885MEN1 1604/4885 |
| US-20120258043-A1 | Linkable Lewis X Analogs | SSB, SELPLG, SELL | AMY1A 3697/4885L3MBTL1 555/4885MEN1 1604/4885 |
| US-20040097403-A1 | Linkable sialyl lewis x analogs | SSB, SELPLG, SELL | AMY1A 3507/4885L3MBTL1 670/4885MEN1 1637/4885 |
| US-20110229409-A1 | LINKABLE LEWIS X ANALOGS | SELPLG, SELL, SELE | AMY1A 2253/4885L3MBTL1 490/4885MEN1 2549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.